$MA also delivered a better-than-expected third-quarter report, but its growth curve is showing signs of slowing. The standout was cross-border transaction volume, up 21% year over year, extending the post-pandemic rebound in cross-border travel and spending. Revenue from value-added services also maintained growth of around 19%, indicating that higher-fee data and risk-management services are becoming a second growth engine.
However, signals from volume and value are diverging: the company disclosed that the total value of payments processed on its platform grew just 11% in the first three weeks of October, below the 14% in August and September and the 13% in July. Management accordingly lowered its revenue growth guidance for the fourth quarter to the low double digits. In other words, travel spending remains robust, but growth in underlying transaction volume is beginning to slow at the margin.
This combination of good, but not quite good enough, is especially important for Mastercard, whose valuation is already far from cheap—the market no longer wants a simple beat, but evidence of acceleration. Between the cross-border tailwind and slowing transactions, which will matter more in determining the stock’s direction from here?
$V reported its results for the fourth quarter of fiscal 2026: net revenue of $12.1 billion, up 13% year over year, and adjusted earnings per share of $3.48, up 17%—both beating expectations. Payment volume grew 9%, processed transactions rose 10% to 74.2 billion, and cross-border volume grew even faster, at 14%. Management said revenue grew at its fastest pace in 15 years, excluding the post-pandemic surge and acquisitions.
Fundamentally, economies of scale continued to kick in: the operating margin rose to about 59.8%, up roughly 2.5 percentage points from a year earlier. The company raised its quarterly dividend by 16% to $0.78 and secured preliminary access to China’s domestic bank card clearing market. But financial flows and valuation tempered enthusiasm: despite the strong results, the stock fell about 1% after hours, as it had already gained roughly 15% year to date and expectations were high. The company had also previously announced plans to cut about 2,600 jobs—behind the efficiency gains from AI is a deliberate pullback in costs. Visa’s growth story remains solid, but continuing to beat expectations is becoming more challenging. Can the latest results from the two payment giants support their lofty valuations?
U.S. spot ETFs related to $BTC saw net inflows of approximately $870 million in a single day on October 29, the highest in nearly five months. BlackRock’s IBIT led the way, attracting about $643 million, while total market holdings are rapidly approaching 1 million coins. This powerful wave of inflows pushed Bitcoin back above $73,000 intraday, just shy of its March all-time high of around $73,800.
However, the structure of this rally is uneven. On the same day, spot Ethereum ETFs saw net inflows of only about $7.6 million, a stark contrast with Bitcoin’s massive inflows. This suggests that new capital clearly favors Bitcoin over the broader altseason narrative. Open interest on exchanges also grew more slowly than trading volume, indicating that leverage has not expanded in tandem.
After a sustained rally, signs of short-term overheating have emerged, driven in part by FOMO. The market is beginning to ask: as ETF institutions’ holdings approach the legendary Satoshi address, how long can marginal buying sustain the rally? For bulls, continued accumulation provides a solid foundation, but this is a question worth weighing carefully before chasing prices higher.
$Sprouts made opening stores its top priority in the third quarter: net sales rose 4.7% year over year to $2.30 billion, with a record 15 new stores opened in a single quarter, bringing the total to 504. But the quality of growth is deteriorating—same-store sales fell 0.9% year over year (versus positive growth of 5.9% a year earlier), gross margin was about 38.2%, down roughly 0.5 percentage points from the same period last year, and EPS of $1.21 came in slightly below the $1.23 consensus. More importantly, the company cut its guidance: it slashed its 2026 full-year same-store sales outlook from “up to +0.5%” to -1.7%, and guided to fourth-quarter same-store sales of -2% to -4% and EPS of just $0.47–$0.51 (nearly half the third quarter’s $1.21). Management attributed the weakness to a challenging consumer environment and an outbreak of cyclospora contamination in lettuce, sending shares down about 17% after hours. In short: store expansion is still powering ahead, but both customer traffic and average basket size are shrinking; expansion can’t hide the same-store engine stalling.
$eBay delivered its strongest growth in years in the third quarter: GMV of $23.2 billion, up 15% year over year (16% excluding foreign exchange impacts); revenue of $3.2 billion, up 14%; and adjusted diluted EPS of $1.51, beating consensus of $1.41. Non-GAAP operating margin widened to 26.3%, while GAAP operating margin widened to 19.2%. The company returned $827 million to shareholders during the quarter, including $689 million in buybacks. The growth engine is clear: the recommerce economy has become the main driver—Depop (acquired for $1.2 billion in July) saw experience improvements, eBay Live set consecutive records and has reached an annualized GMV in the billions of dollars, and TCGplayer’s GMV topped $1 billion over the past 12 months. But the stock rose only about 5% after hours, a restrained reaction: this rebound relies heavily on structural tailwinds in secondhand categories and buybacks boosting per-share earnings. Whether the traditional C2C auction core has truly been reactivated remains unproven at scale.
$T -Mobile put “industry-leading growth” in every metric in the third quarter: service revenue was $19.4 billion, up 6% year over year, with postpaid service revenue—the biggest contributor—at $16.3 billion, up 9%; net income rose 27% to $3.46 billion, and diluted EPS of $3.22 topped both $2.41 in the year-ago quarter and the consensus estimate of $2.89; core adjusted EBITDA increased 11% to $9.6 billion. Account metrics were solid too: net postpaid additions came to 274,000 (about 23,000 above expectations), total postpaid accounts reached 35 million, up 3%, and average monthly revenue per account (ARPA) was $155.73, up 4%. But the stellar results didn’t translate into a brighter outlook: the company kept its full-year postpaid net additions target at the midpoint of its original range (about 1 million), and raised the midpoint of its core adjusted EBITDA guidance by just $100 million, while narrowing the range rather than raising the target. The stock rose only about 2% after hours, suggesting the market had already priced in gains in wireless market share. With a base of 35 million accounts facing potential disruption from SpaceX’s entry into direct-to-satellite service, the real question this earnings report leaves open is: how much longer can growth lead the industry?
$VZ delivered its report card for a “year of transformation”: third-quarter revenue was $34.3 billion, up a modest 1.5%; net income was $5.3 billion; adjusted EPS rose 8.3% to $1.31; and adjusted EBITDA hit a record $13.8 billion, with margins climbing to 40.2%. Customer metrics were a standout: postpaid phone net additions reached 406,000 (more than 8x year over year and the best third quarter in five years), postpaid account net additions hit 137,000, the best in more than a decade, and acquisition promotion costs fell 41%. The company raised its full-year guidance for the third consecutive quarter, projecting adjusted EPS of $5.04–$5.06. More notable was a new deal: a distributed computing framework worth more than $2 billion with AWS, enabling its fiber network to support generative and agentic AI workloads—following a dark fiber agreement with Google worth around $1 billion. Yet the stock opened down only about 2%, suggesting the market has yet to buy into the “telecoms become AI infrastructure” narrative. With subsidies fading and loyal customers taking over, the valuation reset for this slow-growth business is only just beginning.
$RCL raised its full-year guidance in the third quarter and its stock gained over 8%, but fuel is quietly eating into some of the upside. Fundamentals were solid: revenue was about $5.6 billion, up 9% year over year; passenger volumes reached 2.7 million, up 9%, with a load factor of 112%; and adjusted EPS came in at $6.57 (vs. $6.38 expected). The company also raised its 2026 adjusted EPS outlook to $17.85–$17.95. Demand is particularly strong: close-in bookings in Europe and the Caribbean are ahead of expectations, 2027 bookings are running at a high-double-digit lead over historical pace, and repeat guests account for nearly half of passengers. Costs warrant a caveat: net cruise costs excluding fuel fell 1.9%, partly because some expenses shifted to the fourth quarter—not solely due to improved efficiency. Full-year fuel expense is expected to be about $1.345 billion, including roughly $379 million in the fourth quarter, while 58% hedging provides only partial protection. On the capital front, the company announced it will acquire a 50% stake in Sandals/Beaches in a resort deal worth about $3 billion, with contributions to results beginning in 2027. Can strong demand for vacations offset the double squeeze from fuel prices and shifted expenses?
$BA has a record backlog of $745 billion, yet its stock plunged about 10% in a single day. The market is focused on just one thing: the 737 MAX production ramp. Third-quarter revenue rose 4% year over year to $24.2 billion, while net losses narrowed to $116 million (compared with a $5.3 billion loss in the same period last year, largely due to a 777X charge). Commercial airplane deliveries hit 161, the highest since 2018, and Defense revenue climbed 15% to $7.9 billion. The financial picture is actually improving: free cash flow was $464 million, up from $238 million a year earlier, and Boeing laid out its first multiyear targets—about $2 billion in 2026 and a push toward $10 billion in 2029. But management has pushed back its target of stabilizing production at 47 planes a month to early 2027, with the move to 52 a month now delayed until the second half of 2027. Full-year deliveries will fall short of the 500-plane target. The post-wing production stage in Renton is the bottleneck. The 737-7 and 737-10 may have received FAA certification, but the production ramp won’t be linear. With a near-record backlog on one side and a far-off cash-flow trajectory on the other, which do you believe in more: the backlog or the production ramp?
$UPS delivered a “flat volume, fatter profits” report in the third quarter: consolidated revenue rose 6.7% year over year to $22.9 billion. The growth may look modest, but its drivers merit a closer look. U.S. domestic package volume was nearly flat, with growth driven entirely by a 6.1% increase in revenue per package; international revenue per package climbed even more, up 15.0%, while Supply Chain Solutions revenue grew 18.2%, led mainly by healthcare and freight. On the earnings front, adjusted diluted EPS was $1.69 on a non-GAAP basis, and the company raised its full-year revenue guidance to about $92.6 billion and adjusted free cash flow guidance to about $6.1 billion. In terms of capital and efficiency, the company has completed its “glide-down” of lower-quality Amazon volume, while network automation is lowering unit costs. Premium mix has replaced volume as the profit engine. However, goodwill impairment dragged the Supply Chain Solutions operating margin down to 3.1%, a reminder that the transformation still comes with growing pains. As e-commerce package volumes peak, how long can profits supported by pricing and automation keep growing?
According to Bloomberg, semiconductor company $MRVL is in advanced talks to acquire data-center optical components maker Lumentum ($LITE ), with a deal announcement possible as early as next week, though the talks could still fall apart. $MRVL has a market capitalization of about $221 billion, while $LITE is worth about $83 billion. If completed, the deal would rank among the largest tech acquisitions in history. The market’s initial reaction was typical: the buyer’s shares fell about 8%–9% after hours, while the target’s rose about 9%–11%. The pressure on the buyer is easy to understand: it has less than $4 billion in cash, and swallowing a target worth nearly $83 billion would almost certainly require a combination of stock issuance and borrowing. That would add integration risks and fuel doubts that it is “buying at the peak of the AI cycle.” Meanwhile, the seller is being labeled expensive, despite having already booked orders for its products through 2029 and being on track to more than double its revenue this year. What makes this deal unusual is the buyer’s desire to fill gaps in its in-house photonics capabilities and bring chip design and the optical-module supply chain under one roof. The question is whether $MRVL is positioning itself for the next phase of AI infrastructure—or laying the groundwork for impairment losses from a peak-priced acquisition.
$LH reported third-quarter revenue of $3.81 billion, up 6.9% year over year, and adjusted EPS of $4.78, up a robust 14.5%. Both beat expectations, prompting the company to raise its full-year revenue growth guidance by about 50 basis points and the midpoint of its adjusted EPS guidance by 18 cents. On the surface, this looks like a familiar story of “profits growing much faster than revenue.” But another factor is helping drive the upgrade: acquisitions. The company finalized four deals this quarter and afterward—MLM Medical Labs, certain BioReference assets, Myriad’s prenatal testing business, and Millennium Health—and says each will boost adjusted EPS in its first year and recoup its cost of capital within three years. Operating margins expanded in both Diagnostics and Biopharma, reaching 16.7% and 18.3%, respectively, suggesting that cost-cutting is indeed taking hold. But as growth increasingly depends on assets acquired from outside, the quality of this “upgrade” deserves closer scrutiny. Which matters more to you: organic margin growth or the pace of expansion through acquisitions?
$WING’s latest quarterly numbers are a mixed bag: revenue totaled $185.1 million, up 5.3% year over year, but same-store sales fell 5.4%—the second consecutive quarter of decline. Domestic sales per store dropped from $2.06 million to $1.85 million. In other words, nearly all revenue growth came from the 76 new restaurants, while traffic at established locations continued to erode. Yet the stock closed up about 12% that day. The reason wasn’t revenue, but earnings per share: adjusted EPS of $1.08 beat consensus by 6 cents, with roughly $288 million in buyback capacity providing support and management signaling early progress in its turnaround. This looks more like a rally driven by repricing the stock on a per-share earnings basis, while temporarily overlooking weak same-store sales. One concern: the company lowered its full-year same-store sales forecast further, to a decline of 6.5%–7%, and also scaled back its pace of new openings. Can growth fueled by new stores fill the gap enough to support the current valuation?
After integrating the major Commonwealth acquisition, $LPLA cut its latest asset retention estimate from about 90% to about 83%—meaning roughly 7 percentage points more advisor assets are leaving than originally expected. The stock plunged about 15% in a single day after the news. Strategically, this was supposed to be a “scale for market share” deal: acquire a leading independent broker-dealer (IBD), expand the platform’s asset base, and monetize it through future fee revenue and back-office synergies. But the financial and sentiment signals point the other way: the acquisition risk everyone fears—“buying the business, then watching the people leave”—is unfolding faster than modeled. Every percentage point drop in retention directly discounts the synergy assumptions and goodwill. The market priced in the deal’s execution risk all at once with a 15% decline. For a platform brokerage valued on the scale of its advisor assets, what it buys is not a license, but people—and people can leave. So what is a platform brokerage’s moat built on: its licenses or its people?
$WEN received a non-binding, all-cash take-private proposal from a Trian-led consortium—including its largest franchisee, Flynn Group, as well as BlueFive and Sixth Street—offering $7.35 per share. That represents a premium of about 19%–20% over Tuesday’s closing price and implies a current valuation of roughly $1.4 billion. Trian and its partners already own about 16.3% of the shares. The board has formed an independent special committee to evaluate the proposal; no definitive agreement has been reached. The stock closed up about 15% after the news.
Fundamentally, Wendy’s has become a target precisely because its shares have fallen to a bargain price: same-store sales have declined for six consecutive quarters, the stock has lost about 65% over the past two years, and the company plans to close as many as 358 restaurants this year. Its leadership has also turned over frequently in the past two years.
Sentiment-wise, the closing price remains about 3.8% below the $7.35 offer price. That gap both reflects the market’s enthusiasm for the premium and serves as a reminder that the non-binding proposal still faces hurdles, including special committee review and financing arrangements. Peltz, after all, walked away from a deal in 2022. One takeover offer has put a price tag on a company’s troubles.
For a fast-food chain with six straight quarters of declining same-store sales, would going private be a lifeline—or a bargain buy?
$BLCO reported third-quarter revenue of $1.375 billion, up 7% year over year (+8% at constant currency). GAAP net income swung from a loss of $28 million in the year-ago quarter to a profit of $32 million. Adjusted EBITDA was $325 million, with a 23.6% margin, up 460 basis points from a year ago. The company raised its full-year guidance for the third time, lifting the midpoint of its revenue outlook to about $5.5 billion and its adjusted EBITDA outlook to $1.09–$1.14 billion. Its shares surged about 16% that day. Fundamentally, all three major segments grew: dry-eye drug MIEBO revenue rose 42%, consumer brand LUMIFY grew 35%, and premium intraocular lenses rose about 70%. Net leverage also fell from 5.7x to 4.1x. But on closer inspection, nearly all the report’s highlights were in margins, not revenue: the midpoint of full-year EBITDA guidance rose by $65 million, while the revenue midpoint increased by just $10 million. Growth quality still hinges on cost cutting and product mix. There’s also a crack in the financial picture: quarterly interest expense was $95 million, nearly two-thirds of operating income of $155 million, and the interim CEO handover remains unresolved. The market’s 16% cheer seems more like a bet on “marginal improvement” than confirmation of a “trend reversal.” In a slow-growth field like eye care, how far can a rebound driven by margins go?
$PRCH reported third-quarter consolidated revenue of $143.9 million, up 13% year over year. Breaking it down, excluding Reciprocal, its core-business revenue was $140.8 million, up 22%, including $102.8 million in insurance services revenue, up 39%; adjusted EBITDA (excluding Reciprocal) was $44.5 million, up 116%; and net income was $12.2 million. The company raised its full-year guidance for the third consecutive quarter (with midpoint EBITDA on this basis of $138 million, up 79% year over year). This is a “Rule of 80” profit engine: fixed costs are spread across more business, and the underwriting loss ratio is just 24%. The other set of books is Reciprocal: policy count rose 42% year over year, but average premium per policy fell 2%. Porch collects only management fees, with much of the value reflected in non-admitted assets. Add the planned acquisition of Allied Trust, expected to close in Q1 2027 (at less than 4x EBITDA, but bringing integration and regulatory uncertainties). Shares rose about 21% after hours, and short sellers would need more than 18 trading days to cover. This looks more like a short squeeze triggered by an earnings inflection point than a repricing of the business model.
$GKOS, an ophthalmic medical device company, posted record third-quarter net sales of $211 million, up 58% year over year. U.S. glaucoma revenue rose 47%, and corneal health revenue increased 154%. More importantly, adjusted net income was $28.5 million (EPS of $0.47, versus market expectations for a loss), marking its first adjusted profit in eight years, with gross margin at around 88%. Two new products drove the turnaround: the long-acting glaucoma implant iDose TR fueled 47% growth in U.S. glaucoma revenue, while reimbursement for the corneal cross-linking therapy Epioxa accelerated after its J-code was activated in July, generating about $53 million for the quarter. The company raised its 2026 sales guidance from $680–700 million to $775–785 million and, for the first time, gave an initial 2027 target of around $1 billion. But the same release also spelled out the risks: iDose TR is still awaiting a Medicare local coverage determination (LCD), with the final terms and timing unknown. If reimbursement is narrowed, utilization of this growth engine could be directly affected. Shares rose about 18% after hours.
$KLAC reported revenue of $4.14 billion in its latest quarter, up 28.9% year over year—the tenth consecutive quarter of growth. Even more impressive was its guidance: a midpoint of about $4.7 billion in revenue for the December quarter, implying 42.5% year-over-year growth. That’s acceleration, not deceleration. As the world’s leading supplier of semiconductor process-control equipment, its orders are directly tied to three major AI growth drivers: advanced process nodes, HBM capacity expansion, and advanced Chiplet packaging. It generated $1.53 billion in operating cash flow that quarter, with a free-cash-flow margin of 32.3%, making it one of the few parts of the current AI infrastructure buildout that reliably generates cash. But from another perspective, KLA has no end-market demand of its own; its entire runway depends on capital spending by wafer fabs and hyperscalers. In the same week, capital spending by several giants in the previous quarter came in unusually below analysts’ expectations, putting a pause on concerns that “AI is only burning cash, not generating returns”—but also underscoring that if customers tighten their purse strings, equipment makers’ high growth will be among the first things cut. The stock rose only about 3.2% after hours, suggesting the market may already be pricing in the cyclical nature of these impressive results.